State Street
PROK icon

State Street’s ProKidney PROK Stock Holding History

State Street’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$997K Buy
556,845
+76,500
+16% +$162K ﹤0.01% 3488
2025
Q4 		$1.08M Buy
480,345
+5,388
+1% +$14.2K ﹤0.01% 3516
2025
Q3 		$1.15M Buy
474,957
+121,350
+34% +$323K ﹤0.01% 3479
2025
Q2 		$209K Sell
353,607
-1,372,716
-80% -$1.07M ﹤0.01% 3821
2025
Q1 		$1.51M Sell
1,726,323
-11,541
-0.7% -$16K ﹤0.01% 3334
2024
Q4 		$2.94M Buy
1,737,864
+309,546
+22% +$558K ﹤0.01% 3186
2024
Q3 		$2.74M Buy
1,428,318
+198,836
+16% +$451K ﹤0.01% 3210
2024
Q2 		$3.02M Buy
1,229,482
+286,883
+30% +$770K ﹤0.01% 3141
2024
Q1 		$1.55M Sell
942,599
-38,792
-4% -$57K ﹤0.01% 3359
2023
Q4 		$1.75M Buy
981,391
+73,544
+8% +$158K ﹤0.01% 3355
2023
Q3 		$4.16M Sell
907,847
-82,412
-8% -$789K ﹤0.01% 3012
2023
Q2 		$11.1M Buy
990,259
+929,878
+1,540% +$9.9M ﹤0.01% 2596
2023
Q1 		$684K Buy
60,381
+9,258
+18% +$98.5K ﹤0.01% 3645
2022
Q4 		$351K Buy
+51,123
New +$488K ﹤0.01% 3891

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street's PROK Position: Q1 2026 in Review

State Street increased its ProKidney (PROK) stake by 16% in Q1 2026, buying an estimated $162K and bringing the position to 556,845 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #3488.

State Street first reported a position in PROK in Q4 2022 and has held it in 14 quarters since. The position peaked at $11.1M in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • State Street held 556,845 shares of ProKidney worth $997K as of Q1 2026.
  • State Street bought 76,500 ProKidney shares in Q1 2026, an estimated $162K.
  • ProKidney made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3488 holding.
  • State Street first reported a position in ProKidney in Q4 2022 and has held it in 14 quarters since.
  • State Street's ProKidney position peaked at $11.1M in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.